ASTX-295
- Generic Name
- ASTX-295
Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53
- First Posted Date
- 2019-06-05
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Taiho Oncology, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT03975387
- Locations
- 🇺🇸
Columbia University Irving Medical Center - Herbert Irving Pavilion Site#104, New York, New York, United States
🇺🇸Cedars-Sinai Medical Center Site #105, Los Angeles, California, United States
🇺🇸City of Hope Comprehensive Cancer Center Site#114, Duarte, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath